![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 19, 2020 8:37:56 PM
Some posts here take a small investment of time. Its frustrating when they get lost.
I still need to read the s1 and understand this Pipe investor concept.
I think CYDY's timeline is being underestimated by most. The Tuesday release is a top line description of results. Another 3 weeks will go into the written response to FDA. FDA will then take at least 2 weeks to give an expedited EUA. FDA will probably want to see P2 M/M and P3 S/C trial results together for one approval which will delay approval to September.
There is a VERY good chance that HGEN is just as far along or further with their P3 trial but Durrant is tight lipped. I think that's probably for the best!
On the balance of it all, the HGEN P3 clinical trial sites are in COVID hot spots right now. CYDY P3 trial sites do not have as much COVID outbreak activity by comparison (even NYC).
It'll be interesting over the next few weeks for sure!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM